Biological E to submit final data on its COVID-19 vaccine Corbevax till November end: Sources


By Shalini Bhardwaj

New Delhi [India], October 14 (ANI): Biologics will submit the final data on the COVID-19 vaccine Corbevax by the end of November, informed government sources on Thursday.

The government was hoping to submit Phase III data for organic e by October, but after facing delays in procuring raw materials, Hyderabad-based organic e was expected to apply for an emergency use authorization of Corbevax by the end of November. have hope.

Corbevax is the third vaccine manufactured in India against coronavirus, the other two indigenous vaccines being Covaxin and ZyCoV-D. The government had earlier announced about 30 crore doses of Corbevax till December.

Earlier, on September 2, NITI Aayog member (health) VK Paul had said that the Hyderabad-based pharmaceutical company, is looking forward to launch its vaccine against coronavirus in October this year.

Paul had told ANI that the Phase III trial of Biological E is going on. “The stockpile is being produced. We must wait for the results. We expect it to be in the next month or two. They have made a broad commitment that they will supply a significant amount by the end of the year.”

The Union Health Ministry announced in June that Biologicals E would supply 300 million doses of Corbevax to India by December.

The Drug Controller General of India (DCGI) on Wednesday allowed the company to conduct Phase 2/3 clinical trials of ‘Made in India’ COVID-19 vaccine for children aged 5-18 years on certain conditions, sources told ANI . .

In addition, he said testing would be conducted at 10 sites in the county. “Organic E has been allowed after the recommendation of the subject expert committee,” he said.

Significantly, the government has made an advance payment of Rs 1,500 crore to Biologicals E for 30 crore vaccines. (ANI)


Leave a Reply